Coherus Oncology, Inc.

CHRS

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001512762

SEC filings (opens in a new tab)

No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Coherus Oncology, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of CHRS: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	114	4	128	+18
Shares	51.6M	52.5K	57.1M	+5.56M (+10.8%)
Value	$84.6M	$87.9K	$81.1M	−$3.46M (−4.1%)

4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Coherus Oncology, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to CHRS in Q4 2025
Institution	Shares	Value	% of portfolio
Timothy G. Youngquist 2020 Irrevocable Trust	5,895,349	$8.37M	7.17%
Nomura Asset Management International Inc.	899,999	$1.28M	0.00%
Millennium Management LLC	660,451	$937.8K	0.00%
Gsa Capital Partners LLP	477,481	$678.0K	0.06%
Squarepoint Ops LLC	92,756	$131.7K	0.00%
Marshall Wace, LLP	85,464	$121.4K	0.00%
SEI Investments Co	76,629	$108.8K	0.00%
Kestra Private Wealth Services, LLC	20,000	$28.4K	0.00%
China Universal Asset Management Co., Ltd.	19,696	$28.0K	0.00%
Bronte Capital Management Pty Ltd.	19,282	$27.4K	0.00%
Blair William & Co	19,000	$27.0K	0.00%
Sagewood Asset Management LP	14,732	$20.9K	0.01%
Wealth Group, Ltd.	14,195	$20.0K	0.02%
Victory Capital Management Inc	11,835	$16.8K	0.00%
Endowment Wealth Management, Inc.	11,521	$16.4K	0.01%
EFG International AG	11,500	$16.3K	0.00%
StoneX Group Inc.	11,002	$15.6K	0.00%
Mariner, LLC	10,890	$15.4K	0.00%
HRT Financial LP	10,527	$14.0K	0.00%
Mirae Asset Global Investments Co., Ltd.	5,874	$8.34K	0.00%
GF Fund Management Co. Ltd.	2,301	$3.27K	0.00%
Farther Finance Advisors, LLC	2,012	$2.86K	0.00%
GAMMA Investing LLC	407	$578	0.00%
SJS Investment Consulting Inc.	88	$125	0.00%
Rothschild Investment LLC	59	$84	0.00%
Sunbelt Securities, Inc.	16	$23	0.00%

Sold out (8)

Institutions that held Coherus Oncology, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of CHRS in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Macquarie Group Ltd	899,999	$1.48M
Citadel Advisors LLC	331,155	$543.1K
Colony Group, LLC	42,986	$135.3K
MetLife Investment Management	63,678	$104.4K
Quadrature Capital Ltd	18,172	$29.7K
Quarry LP	15,572	$25.5K
Prudential Financial Inc	14,980	$24.6K
Riverview Capital Advisers, LLC	12,946	$21.2K

Not filed for Q4 2025 yet (4)

Institutions that held Coherus Oncology, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CHRS in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Wolverine Trading, LLC	30,360	$51.6K
CIBC Bancorp USA Inc.	11,306	$18.5K
Cubist Systematic Strategies, LLC	10,789	$17.7K
AllSquare Wealth Management LLC	16	$26